Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Board Changes

30 Mar 2020 07:01

RNS Number : 9565H
Kier Group PLC
30 March 2020
 

Kier Group plc

Board Changes

Kier Group plc (the "Company" or the "Group") announces the appointments of Mr. Clive Watson and Dame Heather Rabbatts to its board of directors (the "Board") with immediate effect.

Clive Watson is currently a non-executive director of Breedon Group plc and discoverIE Group plc, where he is the Chair of the Audit and Risk Committee, having previously been a non-executive director of Spirax-Sarco Engineering plc, where he was the Senior Independent Director and the Chair of the Audit Committee. During his executive career, Clive was the Group Finance Director at Spectris plc from 2006-2019, having previously held a number of senior finance positions at Borealis, Thorn Lighting Group and The Black & Decker Corporation.

Clive will be the Chair of the Risk Management and Audit Committee and a member of the Nomination Committee, the Remuneration Committee and the Safety, Health and Environment Committee.

Justin Atkinson will stand down from the role of acting Chair of the Risk Management and Audit Committee with immediate effect and continue in the role of Senior Independent Director.

Heather Rabbatts has held a number of executive and non-executive positions in the local government, entertainment and sport sectors, in particular. Heather is currently the Chair of Soho Theatre Company and her recent non-executive directorships include Crossrail, the Football Association, where she was a member of the Remuneration Committee, and Grosvenor Britain & Ireland, where she was the Chair of the Audit Committee.

Heather will be the Chair of the Remuneration Committee and a member of the Nomination Committee, the Risk Management and Audit Committee and the Safety, Health and Environment Committee.

Constance Baroudel, the current Chair of the Remuneration Committee, will stand down from the Board with immediate effect.

Matthew Lester, Chairman, said: "We are delighted that Clive and Heather will be joining the Board. Both have a depth of experience which will be invaluable as the Board continues to oversee the delivery of the Group's strategic objectives. I look forward to working with Clive and Heather.

I would like to thank Constance for her contribution over almost four years on the Board. I would also like to thank Justin for undertaking the role of Chair of the Risk Management and Audit Committee on an interim basis.

As the Chair of the Remuneration Committee, Heather will be engaging with shareholders with respect to the Company's revised remuneration policy, which will assist her to understand the reasons for the significant vote against the Directors' Remuneration Report at the 2019 AGM and to consider any actions which may need to be taken as a result."

In relation to the appointment of Clive Watson, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

In relation to the appointment of Heather Rabbatts, no information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Further information

Please contact:

 

Kier Press Office 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI Consulting 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMZGZFRLKGGZM
Date   Source Headline
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:33 amRNSTransaction in Own Shares
21st Jan 20252:11 pmRNSDirector/PDMR Shareholding
21st Jan 20257:01 amRNSLaunch of £20m share buyback programme
21st Jan 20257:00 amRNSTrading Update
2nd Jan 202511:05 amRNSBlock listing Interim Review
20th Dec 202411:20 amRNSDirector/PDMR Shareholding
13th Dec 20241:11 pmRNSDirector/PDMR Shareholding
10th Dec 20243:34 pmRNSDirector/PDMR Shareholding
6th Dec 202410:37 amRNSHolding(s) in Company
5th Dec 20249:14 amRNSNotification of Change of Director Details
4th Dec 20244:43 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:39 pmRNSTotal Voting Rights
20th Nov 20244:03 pmRNSDirector/PDMR Shareholding
18th Nov 202411:47 amRNSHolding(s) in Company
14th Nov 20242:45 pmRNSResult of AGM
14th Nov 20247:00 amRNSAGM Trading Update
13th Nov 20242:58 pmRNSHolding(s) in Company
8th Nov 202410:36 amRNSDirector/PDMR Shareholding
4th Nov 20245:28 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20243:21 pmRNSDirector/PDMR Shareholding
29th Oct 202411:26 amRNSBlock Listing Application
22nd Oct 202412:47 pmRNSDirector/PDMR Shareholding
16th Oct 20244:23 pmRNSAnnual Financial Report Amendment
14th Oct 20242:53 pmRNSDirector/PDMR Shareholding
4th Oct 202412:00 pmRNSAnnual Financial Report
1st Oct 202412:09 pmRNSTotal Voting Rights
23rd Sep 20242:03 pmRNSHolding(s) in Company
23rd Sep 202410:21 amRNSDirector/PDMR Shareholding
12th Sep 20247:05 amRNSDirectorate Change
12th Sep 20247:00 amRNSFY24 Results
6th Sep 20242:29 pmRNSHolding(s) in Company
2nd Sep 202412:33 pmRNSTotal Voting Rights
22nd Aug 20241:51 pmRNSDirector/PDMR Shareholding
12th Aug 20245:32 pmRNSNotice of Results and Presentations
1st Aug 20249:59 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSFull Year 2024 Trading Update
16th Jul 20243:38 pmRNSHolding(s) in Company
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:28 amRNSTotal Voting Rights
28th Jun 20244:34 pmRNSDirector/PDMR Shareholding
27th Jun 20244:20 pmRNSHolding(s) in Company
20th Jun 202411:53 amRNSDirector/PDMR Shareholding
13th Jun 20243:10 pmRNSDirector/PDMR Shareholding
7th Jun 202410:41 amRNSDirector/PDMR Shareholding
4th Jun 20244:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.